Cardiovascular involvement in systemic lupus erythematosus: an autopsy study of 27 patients in India

L Panchal1, S Divate, P Vaideeswar

  • 1Department of Pathology, Seth G. S. Medical College, K.E.M. Hospital, Parel, Mumbai-400 012, India.

Insights

Cardiovascular disease (CVD) significantly contributes to mortality in Indian patients with systemic lupus erythematosus (SLE), second only to renal disease. Autopsy findings reveal common cardiac and vascular lesions in SLE patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Pathology

Background:

  • Cardiovascular disease (CVD) is a major cause of death in Western patients with systemic lupus erythematosus (SLE).
  • Limited data exists on CVD prevalence and mortality in Indian SLE patients.
  • This study addresses the data gap regarding cardiac and vascular complications in Indian SLE subjects.

Purpose of the Study:

  • To determine the incidence of cardiac abnormalities and vascular lesions in Indian SLE patients via autopsy.
  • To assess the contribution of these lesions to mortality in SLE patients.
  • To correlate autopsy findings with clinical data and ante-mortem investigations.

Main Methods:

  • Retrospective analysis of autopsy reports from 35 SLE patients over 11 years.
  • Detailed examination of cardiac and vascular pathology in 27 cases with relevant lesions.
  • Correlation of pathological findings with clinical history and investigations.

Main Results:

  • Valvular lesions, including non-bacterial thrombotic endocarditis (33.33%), were most common.
  • Myocarditis (37.03%) and myocardial scarring (25.92%) were frequently observed.
  • Cardiovascular manifestations (29.62%) and renal disease (48.14%) were the primary causes of death.

Conclusions:

  • Cardiovascular disease is a significant cause of mortality in Indian SLE patients.
  • It ranks as the second leading cause of death, following renal disease.
  • Autopsy findings highlight the critical role of cardiac and vascular pathology in SLE mortality.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...